Ocular Therapeutix shares are trading higher after Scotiabank Initiated coverage on the stock with a Sector Outperform rating and announced a $22 price target.
Portfolio Pulse from Benzinga Newsdesk
Ocular Therapeutix shares rose following Scotiabank's initiation of coverage with a Sector Outperform rating and a $22 price target.
October 16, 2024 | 6:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ocular Therapeutix shares increased after Scotiabank initiated coverage with a Sector Outperform rating and set a $22 price target.
The initiation of coverage by Scotiabank with a positive rating and a specific price target is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100